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Introduction: 
Syncope is defined as a sudden temporary loss of consciousness associated with a loss of postural 
tone, with spontaneous recovery that does not require electrical or chemical cardioversion. Syncope is 
a common symptom, accounting for 1% to 6% of hospital admission and up to 3% of emergency 
room visits. Loss of consciousness is also common in healthy young adults, although most do not 
seek medical attention. Syncope is a frequent symptom in the elderly.
            The evaluation and management of syncope has dramatically changed over the past 15 years. 
In the early 1980s, several studies showed that the cause of syncope was often not established, and 
subgroups were identified with high mortality and sudden death rates.1-4   Later a large number of 
studies on electrophysiology testing appeared, which led to a better understanding of the roles and 
limitations of tests in syncope.5-,8  Although tilt table testing started in 1980s, it assumed an important 
role in the evaluation of syncope in 1990s, showing that neurally mediated mechanism is a common 
etiology of unexplained syncope.9-12 
            The purpose of this article is to highlight the clinical approach and management of syncope.
  Approach to the patient with syncope: 
             The proper diagnostic and therapeutic approach requires careful analysis of the patient's 
symptoms and of the clinical findings. No specific battery of tests is ever indicated or is always 
useful. Extensive diagnostic evaluation is generally unnecessary, expensive, and risky. Repeated 
evaluation and hospital admission after an initial complete negative assessment is often unrewarding.
            Since it is clearly impractical to wait to monitor all episodes of syncope in order to arrive at a 
diagnosis with the present technology, clinicians must base their decisions on historical features with 
the presumption that the description of the episode is accurate, complete, and based on common 
sense.13-15  The proper evaluation requires a balance of the judicious use of inpatient and outpatient 
diagnostic modalities. The expense and risk of the procedures and of hospitalization are intensified by 
the possibility of iatrogenic harm caused by diagnostic or therapeutic misadventures.
The History: 
            To evaluate syncope, sound clinical decisions are based on a carefully performed history with 
extreme attention to detail. The history, with its proper interpretation ( Table 1 ) and a directed 
physical examination, is the only appropriate way to guide further diagnostic evaluation. The history 
and physical alone can be diagnostic in 25%-35% of patients.1,4,16  Of those for whom a cause is 
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 1(1): 12-22 (2001)Gupta Anoop Kumar, Yash  Lokhandwala, “Evaluation of Syncope: An Overview”                    13
found, the history and physical alone are sufficient in 75%-85% of patients.4 Specific attention should 
be directed toward: 1) characteristic and length of the episode, 2) patient and  witnessed accounts, 3) 
patient age, 4) concomitant (specially cardiac) disease, 5) associated temporally related symptoms 
(e.g., neurological symptoms, angina, palpitations, and heart failure),6) premonitory (prodromal) 
symptoms, 7) symptoms on awakening (post syncope symptoms), 8) the circumstances, situations 
surrounding the episode, 9) exercise, body position, posture, and emotional state, 10) number, 
frequency, and timing of previous syncopal episodes, 11) medications, and 12) family history. As part 
of the initial assessment, early determination of the presence of heart disease is especially crucial 
because these patients are at the highest risk for death.   
Table 1.  History: Symptoms related to syncopal spell
Physical Examination: 
            The physical examination can provide important clues to support a diagnosis suspected from 
the patient's history. Attention should be directed to the vital signs, the cardiovascular examination, 
and neurological examination ( Table 2 ).
Vital signs: This includes blood pressures in supine, sitting, and standing, initially and after several 
minutes, with attention to change in the heart rate and symptoms. An abrupt drop in blood pressure 
with standing, especially with reproduction of symptoms, suggests volume depletion as a potential 
cause. The heart rate should rise with standing in a volume-depleted patient. In patients with 
idiopathic orthostatic hypotension, diabetes, amylodosis, and autonomic insufficiency, the blood 
pressure can drop over several minutes in the standing position and the heart rate may not change.
            An evaluation of the pulse can provide insight into the presence of a dissecting aneurysm or 
subclavian steal. The carotid impulse may reveal evidence for aortic stenosis but a carotid bruit does 
not provide a direct cause of syncope. It may indicate, however, the presence of other atherosclerotic 
lesions such as coronary artery disease (cardiac cause of syncope) or subclavian artery occlusion 
(subclavian steal-related syncope). Carotid sinus massage can give insight into carotid sinus 
hypersensitivity, which is more common in elderly. There should be no bruit on auscultation of the 
carotid before the massage is performed.
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Cardiovascular   Examination:   This   may   reveal   murmurs   consistent   with   hypertrophic 
cardiomyopathy,   aortic   stenosis,   mitral   valve   prolapse,   tricuspid   regurgitation,   or   pulmonary 
hypertension.   Valsalva   maneuver   can   diagnose   hypertrophic   cardiomyopathy   clinically.    The 
presence of S4 and S3 gallops, are potential indicators of cardiac disease, which may be responsible 
for syncope. An S3 gallop could indicate the presence of congestive heart failure.   Evidence of 
Eisenmenger's syndrome, pulmonic stenosis, prosthetic valve dysfunction, aortic stenosis, or a tumor 
flop can provide further clues for the diagnosis of syncope.
Neurological assessment:  The neurological evaluation may indicate focal or localizing signs or 
evidence for a systemic neurological signs such as Parkinson's disease. Changing neurological signs 
are also important. A new neurological deficit in a patient with syncope should be considered a 
premonitory sign for a cerebrovascular accident.            
Table 2. Physical findings: Key points 
Diagnostic testing: 
            The proper diagnostic approach requires careful analysis of syncope in light of all available 
clinical findings. When used properly, they will increase the diagnostic yield compared to the history 
and physical alone. All testing must be tailored to the patient based on the findings of the history and 
physical examinations and with knowledge of the sensitivity and specificity of each test to identify 
the cause of syncope.  
Baseline laboratory tests: 
            Initial laboratory blood tests are generally not abnormal and they generally do not lead to a 
diagnosis. Hypoglycemia, hyponatremia, hypocalcemia, or renal failure is found in 2% to 3% of 
patients, but these appear to be patients with seizures rather than syncope.1-4   These abnormalities 
are often suspected clinically. Bleeding is generally diagnosed clinically and confirmed by a complete 
blood count or hemoccult tests.
Cardiovascular testing: 
12-lead ECG: 
Although ECG is often abnormal, causes of syncope are rarely assigned (<5% of patients) on the 
basis of ECG and rhythm strip.1-4   An ECG is recommended in all patients with syncope because 
abnormalities found on ECG (such as bundle branch block) may guide further evaluation, or if a 
specific diagnosis is made the findings can be important in immediate decision making.  
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Prolonged ECG monitoring: 
            It has become clear that results of ambulatory monitoring are often difficult to interpret in 
evaluating syncope because of the lack of a "gold standard" for diagnosis of arrhythmias and the 
rarity of symptoms during monitoring. The best way to assess the usefulness of ambulatory 
monitoring is to use presence or absence of symptoms during monitoring.17 Approximately 4% of 
patients have symptoms concurrently with arrhythmias, and 17% have symptoms but no arrhythmias, 
thus potentially excluding arrhythmias as a cause of symptoms. In approximately 79% of patients 
there are no symptoms, but brief arrhythmias are found in 13%. In the absence of symptoms during 
monitoring, finding brief or no arrhythmias does not exclude arrhythmic syncope. Brief arrhythmias 
are nonspecific and can be found in asymptomatic healthy individuals. Additionally, absence of 
arrhythmias on monitoring does not exclude arrhythmic syncope because arrhythmias are episodic 
and may not be captured during monitoring. In patients with high pretest probability of arrhythmias 
such as brief sudden loss of consciousness without prodrome, patients with abnormal ECG, or those 
with structural heart disease, arrhythmias are still of concern and further testing is needed. Holter 
monitoring for 72 hours rather than for 24 hours does not yield greater numbers of symptomatic 
periods.18 
Long-term ambulatory loop event monitoring: 
            Loop event monitor can be activated after a syncopal episode, and can record 2 to 5 minutes 
of rhythm strips prior to the activation and 30 to 60 seconds of the rhythm after the activation. 
Tracings can be transmitted via telephone and monitors can be worn for weeks to months. Studies of 
loop monitoring show that arrhythmias with symptoms are found in 8% to 20% of patients. In 
additional 27%, there are symptoms without concurrent arrhythmias.19  This test is recommended in 
patients with recurrent event during the monitoring period. 
Electrophysiological studies: 
            In patients with structural heart disease and/or abnormal ECG, the diagnostic yield of EPS is 
approximately 50%, whereas it is only 10% in patients without structural heart disease.  5-8  
Bradyarrhythmias are much more likely to be diagnosed in patients with conduction disease on 
surface ECG, however, the sensitivity and specificity of EPS for detection of bradyarrhythmias is 
low.
             It is recommended that patients with structural heart disease or abnormal ECG undergo 
electrophysiological testing if clinical assessment is suggestive of arrhythmic syncope and if 
noninvasive testing with Holter or loop monitoring has been non-diagnostic.  
Signal-Averaged ECG: 
            Finding low-amplitude signals (late potentials) has a sensitivity of 73% to 89% and specificity 
of 89% to 100% for prediction of inducible sustained ventricular tachycardia by EPS.20,21  This test 
may be useful in deciding if there is a need for electrophysiological studies for diagnosis of 
ventricular tachycardia when these arrhythmias are the only concern. However, EPS is often 
performed for diagnosis of tachyarrhythmias. This test is not likely to be useful under such 
circumstances because complete assessment is needed.  
Carotid Massage: 
            In the absence of symptoms reproduction, carotid sinus syncope is likely when carotid sinus 
hypersensitivity is found and either 1) spontaneous episode are related to activities that press or 
stretch the carotid sinus or 2) patient has recurrent syncope with a negative work-up.
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            Survival of patients with carotid sinus hypersensitivity is similar to that of general population 
and largely related to underlying disease. Survival appears to be unrelated to pacemaker therapy.22 
Symptoms recur in 20% to 25% of untreated or medically treated patients with carotid sinus 
syndrome.
            Carotid massage is recommended when symptoms are suggestive of carotid sinus syncope and 
in elderly patients with unexplained syncope. Although carotid sinus massage is usually performed in 
the supine position, performing massage during head-up tilt testing may increase the diagnostic yield. 
This was illustrated by one study of 80 patients with unexplained syncope, 30 controls, and 16 
patients with syncope not related to carotid sinus hypersensitivity . 23 Carotid sinus hypersensitivity 
was elicited by carotid sinus massage in the supine position in 8.7 percent of those with unexplained 
syncope; when repeated during tilt table testing, carotid hypersensitivity was observed in 60 percent. 
Among controls and those with syncope of other causes, the incidence of carotid hypersensitivity was 
similar with and without the tilt table test (6.6 and 6.3 percent, respectively).  
Echocardiogram: 
            Echocardiography in the absence of clinical evidence of organic heart disease generally does 
not reveal unexpected findings that lead to an etiology for syncope.24  This test is not recommended 
for screening purpose in patients with syncope.  
Exercise testing: 
            The yield of exercise testing in the diagnosis of the etiology of syncope is very low (<1%). 
Exercise testing is useful as an ancillary diagnostic test for evaluation of ischemic heart disease in 
patients with arrhythmic syncope, particularly ventricular tachycardia. In these patients, in addition to 
the treatment of ventricular tachyarrhythmia, the management of underlying cardiac disease is 
critical. Exercise ECG is also recommended for the evaluation of symptoms with exercise and post 
exertional syncope.  
Upright Tilt Testing: 
            The tilt table test (also called the upright tilt table test) has become a commonly performed 
test for the evaluation of syncope, particularly in young, otherwise healthy patients in whom the 
diagnosis of vasovagal or neurocardiogenic syncope is often entertained . 11,25   It is also useful in 
older persons with suspected neurally mediated syncope.26  Maintaining the patient in an upright 
position for a brief duration on a tilt table has become a common means of testing for predisposition 
to vasovagal syncope. It is widely accepted that hypotension and /or bradycardia during upright tilt 
testing is equivalent to spontaneous vasovagal syncope. This is supported by the fact that the 
temporal sequence of blood pressure and heart rate changes during tilt testing is similar to 
spontaneous spells. In addition, catecholamine release immediately prior to tilt-induced syncope is 
similar to spontaneous vasovagal faint.
            Two general types of testing procedures include upright tilt testing alone (passive testing) and 
tilt testing in conjunction with a chemical agent.9-12   A vast majority of the reported studies employ 
passive testing or use isoproterenol after a brief period of passive tilt testing.             
There are various positive response patterns seen during head-up tilt table testing. 1) Classical 
vasovagal (or neurocardiogenic), which is characterized by the sudden onset of hypotension with or 
without coexistent bradycardia. Vasovagal response can be cardioinhibitory, pure vasodepressor, or 
mixed type. 2) dysautonomic response, characterized by gradual parallel decline in systolic and 
diastolic blood pressure, leading to loss of consciousness.3) psychogenic or psychosomatic response, 
these patients experience syncope during tilt testing with no ascertainable alteration in heart rate, 
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blood pressure, electroencephalographic, or transcranial blood flow patterns.4) Postural Orthostatic 
Tachycardia Syndrome (POTS), characterized by an increase in heart rate of at least 30 beats per 
minute (or a maximum heart rate of 120 bpm) within the first 10 minutes upright during the baseline 
tilt, this tachycardia is not associated with profound hypotension.
Response to tilt table test – The test is usually performed in an electrophysiology laboratory using a 
special tilt table; isoproterenol is often infused if the initial tilt test is negative.27 Occasional patients 
have a pronounced cardioinhibitory response to this test characterized by symptomatic hypotension, 
bradycardia, or both . In one series, 77 of 179 patients (43 percent) with unexplained syncope had a 
positive tilt test; 10 of these patients developed asystole, often associated with seizures, requiring a 
brief period of cardiopulmonary resuscitation.28 
The false negative rate of the upright tilt table test is as high as 14 percent and up to 30 percent when 
isoproterenol is infused 29,30  and is less specific in the elderly.31 The mechanism for syncope during 
tilt table testing is different in normal and patients with a history of neurocardiogenic syncope. One 
study compared 8 normal with and 8 normal without a positive tilt table test and 15 patients with 
neurocardiogenic syncope.32 Patients with neurocardiogenic syncope had a shorter time to syncope 
than normal subjects with a false positive study; an immediate and persistent drop in mean blood 
pressure, suggesting impaired vascular resistance response; more rapid peripheral pooling of blood, 
as determined by left ventricular end-diastolic dimension on echocardiography; and higher peak 
epinephrine levels.
Tilt table testing should not be performed in a patient who is orthostatic at baseline or who has had 
near-syncope without overt loss of consciousness. The utility of the tilt table test depends upon the 
study population. One report evaluated the role of this test in 145 patients with a history of 
presyncope or syncope. The following findings were noted 33 :
  •  Patients with recurrent syncope were more likely to have a positive test compared to those with a 
single episode or with recurrent presyncope (41 versus 17 percent, p<0.005).
  •  Patients with structural heart disease or with a noncardiovascular cause for syncope were less 
likely to have a positive test (16 versus 42 percent, p<0.0001).
  •  When multiple factors were combined, the yield ranged from 0 percent in patients under 50 
without recurrent syncope who had structural heart disease or a noncardiovascular cause to 73 percent 
in those over 50 with recurrent syncope who did not have structural heart disease or a non-
cardiovascular cause.
  •  The additional yield of positive tests with the use of isoproterenol or edrophonium was 10 percent.
Another study evaluated the role of the tilt study in patients with bifascicular block who had 
unexplained syncope. When compared to those with bifascicular block and no syncope, no difference 
in the incidence of a positive tilt test was observed, suggesting that test specificity in this population 
is of concern.34 Tilt testing is also of limited value for patients with situational vagal syncope, i.e., 
syncope due to situations associated with enhanced vagal tone such as micturition, defecation, cough, 
or vomiting.35 
Protocol for tilt table testing – The basic facilities and equipment necessary for performing a tilt 
table test are straightforward. The test should be performed in a quiet room with minimal distractions 
for the patient. The patient should be placed on a hydraulic lift or swinging bed capable of moving 
the patient passively from a supine position to a head-up position between 60° and 90°. The table 
must also have a footboard and safety restraints. Continuous ECG and noninvasive blood pressure 
monitoring are employed throughout the test. Patients should  be  encouraged  to  help  identify 
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symptoms that may develop. An  infusion  pump and intravenous catheter  are necessary  for 
administration of fluids and isoproterenol if indicated. Patients should be in a semi fasting state 
without orthostatic blood pressure changes at baseline.
A variety of protocols have been described for the test that vary in the angle of tilt (60° to 90°), 
duration of tilt (10 to 60 minutes), and the administration of isoproterenol. In general, the patient is 
monitored in the supine position for 5 minutes to obtain baseline heart rate and blood pressure 
measurements. The patient is then positioned in a head-up tilt position. Blood pressure, heart rate, and 
symptoms are recorded every 3 to 5 minutes and the ECG is recorded continuously. If the patient 
experiences loss of consciousness or is unable to maintain posture in association with a significant 
fall in blood pressure or heart rate, he or she is returned to a supine position, and the test is considered 
positive. If, after a period of 10 to 60 minutes, no symptoms have developed, the patient is returned to 
the supine position.
If the patient has remained asymptomatic, the majority of investigators will perform a second tilt 
while infusing isoproterenol.27 One study found that a single-stage isoproterenol tilt table test more 
frequently induced syncope than a standard passive tilt study (56 versus 32 percent) and reduced the 
time necessary for the procedure. There was, however, a lower specificity (83 versus 91 percent for 
standard tilt testing).36  Although isoproterenol increases the frequency of positive tests, it also 
increases the number of false positive results and decreases the specificity of the tilt table test. The 
infusion of isoproterenol is usually titrated to achieve a 20 to 30 percent increase in the baseline heart 
rate while the patient is supine. The patient is then placed in the head-up tilt position for an additional 
20 to 30 minutes.
Many investigators require either loss of consciousness or postural tone to consider the test positive 
while isoproterenol is infused. A modest decrease in blood pressure with symptoms is common with 
isoproterenol and nonspecific.
Although a controlled infusion of isoproterenol is safe in patients without heart disease, it should not 
be used in those with coronary artery disease since angina and serious arrhythmia can be provoked 
.37,38
In order to reduce the time necessary for the tilt test, one study of 109 patients reported that a heart 
rate change ≤ 18 beats per minute during the first six minutes of the test prospectively predicted a 
negative tilt table study with a 96.4 percent specificity, 98.4 percent positive predictive accuracy and 
87.3 percent sensitivity, even with the subsequent use of isoproterenol.39 
Adenosine and nitrates – Adenosine may have a complementary role to the tilt table test in the 
evaluation of patients with possible vasovagal syncope, since it may increase sympathetic discharge 
by activation of cardiovascular afferent nerves; importantly, the use of adenosine requires less time, 
often less than 10 minutes. One study, for example, evaluated the utility of adenosine (given as 6 and 
12 mg boluses) compared to head-up tilt-table testing in 85 patients presenting with syncope and in 
14 normal controls .40  A vasovagal response was defined as the development of syncope or 
presyncope associated with relative bradycardia and/or hypotension (decrease in systolic blood 
pressure ≥ 30 mmHg) occurring 15 to 60 sec after adenosine injection or during the tilt table test. The 
inducibility of a vasovagal response with adenosine was comparable to that with the tilt table test in 
patients with syncope (26 and 34 percent) and in normal (7 percent for both tests). These observations 
also suggest that adenosine may be an endogenous modulator of the vasovagal response.41 
However, a second study of 100 patients found that, despite a similar yield, results with adenosine 
and routine tilt table study were discordant in 21 percent of patients; however, most of the patients 
with a positive response to adenosine but negative tilt table study had a positive response with the use 
of isoproterenol, suggesting that adenosine and isoproterenol tilt testing have complementary roles.41 
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Another pharmacological agent that may have a complementary role to the tilt table study is 
sublingual or intravenous nitrates.42-44  In one report, the use of sublingual isosorbide dinitrate 
increased the frequency of a positive tilt study among patients with a history of vasovagal syncope 
from 13 to 87 percent, although the number of normal with a positive tilt study also increased from 0 
to 6 percent .42 One study compared sublingual nitroglycerin to isoproterenol in 71 patients with 
unexplained syncope and 30 controls and found that the diagnostic accuracy was similar; however, 
sublingual nitroglycerin was simpler to use, better tolerated, and safer than low-dose isoproterenol .45 
Clomipramine – Acute clomipramine administration blocks the reuptake of serotonin in the synapse 
space   and   increases   stimulation   of   serotonin   receptors   and   responsiveness   of   the   central 
serotoninergic nervous system in subjects with vasovagal syncope; this leads to sympathetic 
withdrawal. One study of 55 patients with a history of neurocardiogenic syncope found that an 
intravenous infusion of clomipramine (5 mg in 5 min) increased the number of patients with a 
positive tilt table test (80 versus 53 percent without clomipramine); only 1 of 22 controls had a 
positive test with the drug.46 
            Upright tilt testing is recommended for patients with recurrent  unexplained syncope in whom 
cardiac causes have been excluded or are not likely. In patients with negative passive tests and a high 
likelihood of neurally mediated syncope clinically (e.g., young person with concurrent autonomic 
symptoms), additional testing with isoproterenol is recommended.  
Neurological testing: 
             Generally, skull films, lumbar puncture, radionuclide brain scan, carotid Doppler's, and 
cerebral angiography do not yield diagnostic information for a cause of syncope in the absence of 
clinical findings that are suggestive of a specific neurological process.1  Studies of EEG in syncope 
have shown that an epileptiform abnormality was found in 1% of patients; almost all of these were 
suspected clinically.47  Head CT scans are rarely useful to assign an etiology, but are needed if 
subdural bleed due to head injury is suspected or in patients suspected to have seizures as a cause of 
loss of consciousness.1  
Psychiatric Assessment: 
            Psychiatric illnesses must be considered as a cause of syncope, especially in young patients 
and those with multiple syncopal episodes who also have other nonspecific symptoms.48   The 
disorders that may cause syncope include generalized anxiety and panic disorders, major depression, 
somatization disorder, and alcohol/substance abuse. Screening instruments for these disorders are 
available and recommended.  
Summary and conclusion: 
            Syncope is a common manifestation of many disease processes. In a minority of cases, the 
problem is recurrent and handicapping. Patient with syncope and heart disease, particularly when 
there is impaired left ventricular function, bundle branch block, evidence of congestive heart failure, 
or a positive family history of syncope and heart disease, appear to be at high risk for death and 
require an aggressive initial approach. Patients who benefit most from hospitalization include those 
with suspected cardiac disease, the elderly, those with serious injuries, and those with new 
neurological findings.
             Diagnostic test should be used sparingly, directed by a carefully performed history and 
physical examination. No series of test is universally applicable.
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Figure 1. Approach to syncope
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